Editas Medicine Announces US Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR … – P&T Community

Editas Medicine Announces US Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR … – P&T Community
NPREditas Medicine Announces US Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR …P&T CommunityCAMBRIDGE, Mass., Feb. 15, 2017 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:EDIT) announced today that the U.S. Patent and Trademark Office (USPTO) issued a favorable decision in the CRISPR interference between the University of …Berkeley statement regarding patent board’s decision on CRISPR-Cas9 gene-editing technology | Berkeley NewsUC Berkeley News – University of California, Berkeleyall 53 news articles »
Editas Medicine Announces US Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR … – P&T Community